NM_000350.3:c.455G>A
Variant summary
Our verdict is Likely benign. The variant received -6 ACMG points: 3P and 9B. PM1PP2BP4_StrongBP6BS2
The NM_000350.3(ABCA4):c.455G>A(p.Arg152Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00427 in 1,613,942 control chromosomes in the GnomAD database, including 28 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Synonymous variant affecting the same amino acid position (i.e. R152R) has been classified as Likely benign.
Frequency
Consequence
NM_000350.3 missense
Scores
Clinical Significance
Conservation
Publications
- ABCA4-related retinopathyInheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
- cone-rod dystrophy 3Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P, Ambry Genetics
- severe early-childhood-onset retinal dystrophyInheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Laboratory for Molecular Medicine, Labcorp Genetics (formerly Invitae), Ambry Genetics
- retinitis pigmentosa 19Inheritance: AR Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
- cone-rod dystrophyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- retinitis pigmentosaInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- Stargardt diseaseInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -6 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ABCA4 | ENST00000370225.4 | c.455G>A | p.Arg152Gln | missense_variant | Exon 5 of 50 | 1 | NM_000350.3 | ENSP00000359245.3 | ||
ABCA4 | ENST00000649773.1 | c.455G>A | p.Arg152Gln | missense_variant | Exon 5 of 19 | ENSP00000496882.1 |
Frequencies
GnomAD3 genomes AF: 0.00283 AC: 431AN: 152150Hom.: 3 Cov.: 33 show subpopulations
GnomAD2 exomes AF: 0.00259 AC: 651AN: 251232 AF XY: 0.00258 show subpopulations
GnomAD4 exome AF: 0.00442 AC: 6461AN: 1461674Hom.: 25 Cov.: 32 AF XY: 0.00434 AC XY: 3156AN XY: 727160 show subpopulations
GnomAD4 genome AF: 0.00283 AC: 431AN: 152268Hom.: 3 Cov.: 33 AF XY: 0.00255 AC XY: 190AN XY: 74452 show subpopulations
ClinVar
Submissions by phenotype
not provided Benign:5Other:1
The ABCA4 p.Arg152Gln variant was identified in 5 of 958 proband chromosomes (frequency: 0.005) from individuals or families with Stargardt Disease and Age-related Macular Degeneration and was present in 3 of 440 control chromosomes (frequency: 0.0068) from healthy individuals (Rivera_2000_PMID:10958763; Schulz_2017_PMID:28118664). The variant was also identified in dbSNP (ID: rs62646862), LOVD 3.0 and in ClinVar (classified as likely benign by EGL Genetics, GeneDx and ARUP Laboratories and as likely pathogenic by the University Regensberg Institute of Human Genetics). The variant was not identified in Cosmic. The variant was identified in control databases in 651 of 251232 chromosomes (2 homozygous) at a frequency of 0.002591 increasing the likelihood this could be a low frequency benign variant (Genome Aggregation Database Feb 27, 2017). The variant was observed in the following populations: European (non-Finnish) in 420 of 113574 chromosomes (freq: 0.003698), South Asian in 96 of 30610 chromosomes (freq: 0.003136), Other in 18 of 6136 chromosomes (freq: 0.002934), Latino in 86 of 34578 chromosomes (freq: 0.002487), African in 14 of 16230 chromosomes (freq: 0.000863) and European (Finnish) in 17 of 21646 chromosomes (freq: 0.000785); it was not observed in the Ashkenazi Jewish and East Asian populations. The p.Arg152 residue is not conserved in mammals and four out of five computational analyses (PolyPhen-2, SIFT, AlignGVGD, BLOSUM) do not suggest a high likelihood of impact to the protein; however, this information is not predictive enough to rule out pathogenicity. The variant occurs outside of the splicing consensus sequence and in silico or computational prediction software programs (SpliceSiteFinder, MaxEntScan, NNSPLICE, GeneSplicer) do not predict a difference in splicing. In summary, based on the above information the clinical significance of this variant cannot be determined with certainty at this time although we would lean towards a more benign role for this variant. This variant is classified as likely benign. -
ABCA4: BP4, BS2 -
- -
- -
This variant is associated with the following publications: (PMID: 11702214, 23143460, 22264887, 11385708, 26593885, 14517951, 15192030, 25444351, 28118664, 22328824, 15161829, 10958763, 23953153, 16917483, 26764160, 28898540, 29925512, 30093795, 31456290) -
- -
Stargardt disease Pathogenic:1Other:1
- -
Variant interpretted as Uncertain significance and reported on 06-25-2018 by Lab or GTR ID 239772. GenomeConnect assertions are reported exactly as they appear on the patient-provided report from the testing laboratory. GenomeConnect staff make no attempt to reinterpret the clinical significance of the variant. -
ABCA4-related disorder Uncertain:1Benign:1
This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases did not allow this variant to be ruled in or out of causing disease. Therefore, this variant is classified as a variant of unknown significance. -
This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -
Severe early-childhood-onset retinal dystrophy Uncertain:1
The ABCA4 c.455G>A variant was identified in an individual with retinitis pigmentosa with a presumed recessive inheritance pattern. Through a review of available evidence we were able to apply the following criteria: BS1, PP3. Based on this evidence we have classified this variant as Variant of Uncertain Significance. -
Retinal dystrophy Uncertain:1
- -
not specified Benign:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at